Phage-based enzybiotics

Bacteriophages in Health and Disease

Volumn , Issue , 2012, Pages 217-239

  Shen, Yang ^a   Mitchell, Michael S ^a   Donovan, David M ^b   Nelson, Daniel C ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867061978     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (162)

1. Abedon, S.T. (2011a) Lysis from without. Bacteriophage 1, 46-49.
2. Abedon, S.T. (2011b) Bacteriophages and Biofilms: Ecology, Phage Therapy, Plaques. Nova Science Publishers
3. Akesson, M., Dufour, M., Sloan, G.L. and Simmonds, R.S. (2007) Targeting of streptococci by zoocin A. FEMS Microbiology Letters 270, 155-161.
4. al-Jumaili, I.J. (1976) Physical properties and the fine structure of proteocines. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 235, 421-432.
5. Arnoldi, M., Fritz, M., Bauerlein, E., Radmacher, M., Sackmann, E. and Boulbitch, A. (2000) Bacterial turgor pressure can be measured by atomic force microscopy. Physical Review E Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 62, 1034-1044.
6. Bartell, P.F. and Orr, T.E. (1969a) Origin of polysaccharide depolymerase associated with bacteriophage infection. Journal of Virology 3, 290-296.
7. Bartell, P.F. and Orr, T.E. (1969b) Distinct slime polysaccharide depolymerases of bacteriophage infected Pseudomonas aeruginosa: evidence of close association with the structured bacteriophage particle. Journal of Virology 4, 580-584.
8. Bartell, P.F., Orr, T.E. and Lam, G.K. (1966) Polysaccharide depolymerase associated with bacteriophage infection. Journal of Bacteriology 92, 56-62.
9. Bartell, P.F., Lam, G.K. and Orr, T.E. (1968) Purification and properties of polysaccharide depolymerase associated with phage-infected Pseudomonas aeruginosa. Journal of Biological Chemistry 243, 2077-2080.
10. Bastos, M.C., Ceotto, H., Coelho, M.L. and Nascimento, J.S. (2009) Staphylococcal antimicrobial peptides: relevant properties and potential biotechnological applications. Current Pharmaceutical Biotechnology 10, 38-61.
11. Bateman, A. and Rawlings, N.D. (2003) The CHAP domain: a large family of amidases including GSP amidase and peptidoglycan hydrolases. Trends in Biochemical Sciences 28, 234-237.
12. Becker, S.C., Foster-Frey, J. and Donovan, D.M. (2008) The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiology Letters 287, 185-191.
13. Becker, S.C., Dong, S., Baker, J.R., Foster-Frey, J., Pritchard, D.G. and Donovan, D.M. (2009a) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiology Letters 294, 52-60.
14. Becker, S.C., Foster-Frey, J., Stodola, A.J., Anacker, D. and Donovan, D.M. (2009b) Differentially conserved staphylococcal SH3b_5 cell wall binding domains confer increased staphylolytic and streptolytic activity to a streptococcal prophage endolysin domain. Gene 443, 32-41.
15. Bessler, W., Freund-Mölbert, E., Knufermann, H., Rudolph, C., Thurow, H. and Stirm, S. (1973) A bacteriophage-induced depolymerase active on Klebsiella K11 capsular polysaccharide. Virology 56, 134-151.
16. Borysowski, J., Weber-Dabrowska, B. and Górski, A. (2006) Bacteriophage endolysins as a novel class of antibacterial agents. Experimental Biology and Medicine 231, 366-377.
17. Bradley, D.E. (1967) Ultrastructure of bacteriophage and bacteriocins. Bacteriological Reviews 31, 230-314.
18. Braun, V., Pilsl, H. and Gross, P. (1994) Colicins: structures, modes of action, transfer through membranes, and evolution. Archives of Microbiology 161, 199-206.
19. Briers, Y., Volckaert, G., Cornelissen, A., Lagaert, S., Michiels, C.W., Hertveldt, K. and Lavigne, R. (2007) Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages phiKZ and EL. Molecular Microbiology 65, 1334-1344.
20. Briers, Y., Schmelcher, M., Loessner, M.J., Hendrix, J., Engelborghs, Y., Volckaert, G. and Lavigne, R. (2009) The high-affinity peptidoglycan binding domain of Pseudomonas phage endolysin KZ144. Biochemical and Biophysical Research Communications 383, 187-191.
21. Briers, Y., Walmagh, M. and Lavigne, R. (2011) Use of bacteriophage endolysin EL188 and outer membrane permeabilizers against Pseudomonas aeruginosa. Journal of Applied Microbiology 110, 778-785.
22. Casjens, S.R. and Thuman-Commike, P.A. (2011) Evolution of mosaically related tailed bacteriophage genomes seen through the lens of phage P22 virion assembly. Virology 411, 393-415.
23. Celia, L.K., Nelson, D. and Kerr, D.E. (2008) Characterization of a bacteriophage lysin (Ply700) from Streptococcus uberis. Veterinary Microbiology 130, 107-117.
24. Chavan, M., Rafi, H., Wertz, J., Goldstone, C. and Riley, M.A. (2005) Phage associated bacteriocins reveal a novel mechanism for bacteriocin diversification in Klebsiella. Journal of Molecular Evolution 60, 546-556.
25. Cheng, Q. and Fischetti, V.A. (2007) Mutagenesis of a bacteriophage lytic enzyme PlyGBS significantly increases its antibacterial activity against group B streptococci. Applied Microbiology and Biotechnology 74, 1284-1291.
26. Cheng, Q., Nelson, D., Zhu, S. and Fischetti, V.A. (2005) Removal of group B streptococci colonizing the vagina and oropharynx of mice with a bacteriophage lytic enzyme. Animicrobial Agents and Chemotherapy 49, 111-117.
27. Climo, M.W., Patron, R.L., Goldstein, B.P. and Archer, G.L. (1998) Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrobial Agents and Chemotherapy 42, 1355-1360.
28. Cornelissen, A., Ceyssens, P.J., T'Syen, J., Van Praet, H., Noben, J.P., Shaburova, O.V., Krylov, V.N., Volckaert, G. and Lavigne, R. (2011) The T7-related Pseudomonas putida phage φ15 displays virion-associated biofilm degradation properties. PLoS One 6, e18597.
29. Croux, C., Ronda, C., Lopez, R. and Garcia, J.L. (1993) Interchange of functional domains switches enzyme specificity: construction of a chimeric pneumococcal-clostridial cell wall lytic enzyme. Molecular Microbiology 9, 1019-1025.
30. Cui, F., Li, G., Huang, J., Zhang, J., Lu, M., Lu, W., Huan, J. and Huang, Q. (2011) Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with antimethicillin-resistant Staphylococcus aureus and promotion wound healing properties. Drug Delivery 18, 173-180.
31. Dajcs, J.J., Hume, E.B., Moreau, J.M., Caballero, A.R., Cannon, B.M. and O'Callaghan, R.J. (2000) Lysostaphin treatment of methicillinresistant Staphylococcus aureus keratitis in the rabbit. Investigative Ophthalmology and Visual Science 41, 1432-1437.
32. Dajcs, J.J., Thibodeaux, B.A., Hume, E.B., Zheng, X., Sloop, G.D. and O'Callaghan, R.J. (2001) Lysostaphin is effective in treating methicillinresistant Staphylococcus aureus endophthalmitis in the rabbit. Current Eye Research 22, 451-457.
33. Dajcs, J.J., Austin, M.S., Sloop, G.D., Moreau, J.M., Hume, E.B., Thompson, H.W., McAleese, F.M., Foster, T.J. and O'Callaghan, R.J. (2002) Corneal pathogenesis of Staphylococcus aureus strain Newman. Investigative Ophthalmology and Visual Science 43, 1109-1115.
34. Damasko, C., Konietzny, A., Kaspar, H., Appel, B., Dersch, P. and Strauch, E. (2005) Studies of the efficacy of Enterocoliticin, a phage-tail like bacteriocin, as antimicrobial agent against Yersinia enterocolitica serotype O3 in a cell culture system and in mice. Journal of Veterinary Medicine B Infectious Diseases and Veterinary Public Health 52, 171-179.
35. Daniel, A., Euler, C., Collin, M., Chahales, P., Gorelick, K. and Fischetti, V.A. (2010) Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy.
36. Davidson, I.W., Sutherland, I.W. and Lawson, C.J. (1976) Purification and properties of an alginate lyase from a marine bacterium. Biochemistry Journal 159, 707-713.
37. Davidson, I.W., Lawson, C.J. and Sutherland, I.W. (1977) An alginate lysate from Azotobacter vinelandii phage. Journal of General Microbiology 98, 223-229.
38. Daw, M.A. and Falkiner, F.R. (1996) Bacteriocins: nature, function and structure. Micron 27, 467-479.
39. d'Herelle, F.H. (1917) Sur un microbe invisible antagoniste des bacilles dysenteriques. Comptes Rendus de l'Académie des Sciences (Paris) 165, 373-375.
40. Diaz, E., Lopez, R. and Garcia, J.L. (1990) Chimeric phage-bacterial enzymes: a clue to the modular evolution of genes. Proceedings of the National Academy of Sciences USA 87, 8125-8129.
41. Diaz, E., Lopez, R. and Garcia, J.L. (1991) Chimeric pneumococcal cell wall lytic enzymes reveal important physiological and evolutionary traits. Journal of Biological Chemistry 266, 5464-5471.
42. Djurkovic, S., Loeffler, J.M. and Fischetti, V.A. (2005) Synergistic killing of Streptococcus pneumoniae with the bacteriophage lytic enzyme Cpl-1 and penicillin or gentamicin depends on the level of penicillin resistance. Antimicrobial Agents and Chemotherapy 49, 1225-1228.
43. Donovan, D.M. (2007) Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications. Recent Patents in Biotechnology 1, 113-122.
44. Donovan, D.M. and Foster-Frey, J. (2008) LambdaSa2 prophage endolysin requires Cpl-7-binding domains and amidase-5 domain for antimicrobial lysis of streptococci. FEMS Microbiology Letters 287, 22-33.
45. Donovan, D.M., Lardeo, M. and Foster-Frey, J. (2006a) Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiology Letters 265, 133-139.
46. Donovan, D.M., Dong, S., Garrett, W., Rousseau, G.M., Moineau, S. and Pritchard, D.G. (2006b) Peptidoglycan hydrolase fusions maintain their parental specificities. Applied and Environmental Microbiology 72, 2988-2996.
47. Donovan, D.M., Becker, S.C., Dong, S., Baker, J.R., Foster-Frey, J. and Pritchard, D.G. (2009) Peptidoglycan hydrolase enzyme fusions for treating multi-drug resistant pathogens. Biotech International 21, 6-10.
48. Doyle, R.J. and Marquis, R.E. (1994) Elastic, flexible peptidoglycan and bacterial cell wall properties. Trends in Microbiology 2, 57-60.
49. Dubois, J.Y., Kouwen, T.R., Schurich, A.K., Reis, C.R., Ensing, H.T., Trip, E.N., Zweers, J.C. and van Dijl, J.M. (2009) Immunity to the bacteriocin sublancin 168 is determined by the SunI (YolF) protein of Bacillus subtilis. Antimicrobial Agents and Chemotherapy 53, 651-661.
50. Entenza, J.M., Loeffler, J.M., Grandgirard, D., Fischetti, V.A. and Moreillon, P. (2005) Therapeutic effects of bacteriophage Cpl-1 lysin against Streptococcus pneumoniae endocarditis in rats. Antimicrobial Agents and Chemotherapy 49, 4789-4792.
51. Evans, A.C. (1934) Streptococcus bacteriophage: a study of four serological types. Public Health Reports 49, 1386-1401.
52. Evans, A.C. (1936) Studies on hemolytic streptococci. I. Methods of classification. Journal of Bacteriology 31, 423-437.
53. Evans, A.C. (1940) The potency of nascent Streptococcus bacteriophage B. Journal of Bacteriology 39, 597-604.
54. Fenton, M., Casey, P.G., Hill, C., Gahan, C.G., Ross, R.P., McAuliffe, O., O'Mahony, J., Maher, F. and Coffey, A. (2010) The truncated phage lysin CHAPk eliminates Staphylococcus aureus in the nares of mice. Bioengineered Bugs 1, 404-407.
55. Filatova, L.Y., Becker, S.C., Donovan, D.M., Gladilin, A.K. and Klyachko, N.L. (2010) LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization. Biochimie 92, 507-513.
56. Fischetti, V.A. (2005) Bacteriophage lytic enzymes: novel anti-infectives. Trends in Microbiology 13, 491-496.
57. Fischetti, V.A. (2010) Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens. International Journal of Medical Microbiology 300, 357-362.
58. Fischetti, V.A., Gotschlich, E.C. and Bernheimer, A.W. (1971) Purification and physical properties of group C streptococcal phage-associated lysin. Journal of Experimental Medicine 133, 1105-1117.
59. Foley, S., Bruttin, A. and Brussow, H. (2000) Widespread distribution of a group I intron and its three deletion derivatives in the lysin gene of Streptococcus thermophilus bacteriophages. Journal of Virology 74, 611-618.
60. Folkesson, A., Haagensen, J.A., Zampaloni, C., Sternberg, C. and Molin, S. (2008) Biofilm induced tolerance towards antimicrobial peptides. PLoS One 3, e1891.
61. Fux, C.A., Stoodley, P., Hall-Stoodley, L. and Costerton, J.W. (2003) Bacterial biofilms: a diagnostic and therapeutic challenge. Expert Review of Anti-infective Therapy 1, 667-683.
62. Fyfe, J.A., Harris, G. and Govan, J.R. (1984) Revised pyocin typing method for Pseudomonas aeruginosa. Journal of Clinical Microbiology 20, 47-50.
63. Gaeng, S., Scherer, S., Neve, H. and Loessner, M.J. (2000) Gene cloning and expression and secretion of Listeria monocytogenes bacteriophage-lytic enzymes in Lactococcus lactis. Applied and Environmental Microbiology 66, 2951-2958.
64. Garcia, E., Garcia, J.L., Garcia, P., Arraras, A., Sanchez-Puelles, J.M. and Lopez, R. (1988) Molecular evolution of lytic enzymes of Streptococcus pneumoniae and its bacteriophages. Proceedings of the National Academy of Science USA 85, 914-918.
65. Garcia, J.L., Garcia, E., Arraras, A., Garcia, P., Ronda, C. and Lopez, R. (1987) Cloning, purification and biochemical characterization of the pneumococcal bacteriophage Cp-1 lysin. Journal of Virology 61, 2573-2580.
66. Garcia, P., Garcia, J.L., Garcia, E., Sanchez-Puelles, J.M. and Lopez, R. (1990) Modular organization of the lytic enzymes of Streptococcus pneumoniae and its bacterio phages. Gene 86, 81-88.
67. Garcia, P., Martinez, B., Rodriguez, L. and Rodriguez, A. (2010) Synergy between the phage endolysin LysH5 and nisin to kill Staphylococcus aureus in pasteurized milk. International Journal of Food Microbiology 141, 151-155.
68. Gerova, M., Halgasova, N., Ugorcakova, J. and Bukovska, G. (2011) Endolysin of bacteriophage BFK20: evidence of a catalytic and a cell wall binding domain. FEMS Microbiology Letters 321, 83-91.
69. Grandgirard, D., Loeffler, J.M., Fischetti, V.A. and Leib, S.L. (2008) Phage lytic enzyme Cpl-1 for antibacterial therapy in experimental pneumococcal meningitis. Journal of Infectious Diseases 197, 1519-1522.
70. Gratia, A. (1925) Sur un remarquable exemple d'antagonisme entre deux souches de Colibacille. Comptes Rendus de la Société de Biologie 93, 1040-1041.
71. Gratia, J.P. (1989) Products of defective lysogeny in Serratia marcescens SMG 38 and their activity against Escherichia coli and other Enterobacteria. Journal of General Microbiology 135, 25-35.
72. Gu, J., Xu, W., Lei, L., Huang, J., Feng, X., Sun, C., Du, C., Zuo, J., Li, Y., Du, T., Li, L. and Han, W. (2011) LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. Journal of Clinical Microbiology 49, 111-117.
73. Guterman, S.K., Wright, A. and Boyd, D.H. (1975) Genes affecting coliphage BF23 and E colicin sensitivity in Salmonella typhimurium. Journal of Bacteriology 124, 1351-1358.
74. Hall-Stoodley, L., Costerton, J.W. and Stoodley, P. (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nature Reviews Microbiology 2, 95-108.
75. Hermoso, J.A., Monterroso, B., Albert, A., Galan, B., Ahrazem, O., Garcia, P., Martinez-Ripoli, M., Garcia, J.L. and Menendez, M. (2003) Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Structure 11, 1239-1249.
76. Hermoso, J.A., Garcia, J.L. and Garcia, P. (2007) Taking aim on bacterial pathogens: from phage therapy to enzybiotics. Current Opinion on Microbiology 10, 461-472.
77. Hirokawa, H. and Kadlubar, F. (1969) Length of deoxyribonucleic acid of PBSX-like particles of Bacillus subtilis induced by 4-nitroquinoline-1-oxide. Journal of Virology 3, 205-209.
78. Horgan, M., O'Flynn, G., Garry, J., Cooney, J., Coffey, A., Fitzgerald, G.F., Ross, R.P. and McAuliffe, O. (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Applied and Environmental Microbiology 75, 872-874.
79. Hughes, K.A., Sutherland, I.W. and Jones, M.V. (1998a) Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase. Microbiology 144, 3039-3047.
80. Hughes, K.A., Sutherland, I.W., Clark, J. and Jones, M.V. (1998b) Bacteriophage and associated polysaccharide depolymerases-novel tools for study of bacterial biofilms. Journal of Applied Microbiology 85, 583-590.
81. Ito, Y., Kwon, O.H., Ueda, M., Tanaka, A. and Imanishi, Y. (1997) Bactericidal activity of human lysozymes carrying various lengths of polyproline chain at the C-terminus. FEBS Letters 415, 285-288.
82. Jabrane, A., Sabri, A., Compere, P., Jacques, P., Vandenberghe, I., Van Beeumen, J. and Thonart, P. (2002) Characterization of serracin P, a phage-tail-like bacteriocin and its activity against Erwinia amylovora, the fire blight pathogen. Applied and Environmental Microbiology 68, 5704-5710.
83. Jado, I., Lopez, R., Garcia, E., Fenoll, A., Casal, J. and Garcia, P. (2003) Phage lytic enzymes as therapy for antibiotic-resistant Streptococcus pneumoniae infection in a murine sepsis model. Journal of Antimicrobial Chemotherapy 52, 967-973.
84. Kasparek, P., Pantucek, R., Kahankova, J., Ruzickova, V. and Doskar, J. (2007) Genome rearrangements in host-range mutants of the polyvalent staphylococcal bacteriophage 812. Folia Microbiologica 52, 331-338.
85. Kassa, T. and Chhibber, S. (2012) Thermal treatment of the bacteriophage lysate of Klebsiella pneumoniae B5055 as a step for the purification of capsular depolymerase enzyme. Journal of Virological Methods 179, 135-141.
86. Keren, I., Kaldalu, N., Spoering, A., Wang, Y. and Lewis, K. (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiology Letters 230, 13-18.
87. Kokai-Kun, J.F., Walsh, S.M., Chanturiya, T. and Mond, J.J. (2003) Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrobial Agents and Chemotherapy 47, 1589-1597.
88. Kokai-Kun, J.F., Chanturiya, T. and Mond, J.J. (2007) Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. Journal of Antimicrobial Chemotherapy 60, 1051-1059.
89. Korndorfer, I.P., Danzer, J., Schmelcher, M., Zimmer, M., Skerra, A. and Loessner, M.J. (2006) The crystal structure of the bacteriophage PSA endolysin reveals a unique fold responsible for specific recognition of Listeria cell walls. Journal of Molecular Biology 364, 678-689.
90. Korndorfer, I.P., Kanitz, A., Danzer, J., Zimmer, M., Loessner, M.J. and Skerra, A. (2008) Structural analysis of the L-alanoyl-D-glutamate endopeptidase domain of Listeria bacteriophage endolysin Ply500 reveals a new member of the LAS peptidase family. Acta Crystallographica D Biological Crystallography 64, 644-650.
91. Kumar, J.K. (2008) Lysostaphin: an antistaphylococcal agent. Applied Microbiology and Biotechnology 80, 555-561.
92. Lai, M.J., Lin, N.T., Hu, A., Soo, P.C., Chen, L.K., Chen, L.H. and Chang, K.C. (2011) Antibacterial activity of Acinetobacter baumannii phage varphiAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria. Applied Microbiology and Biotechnology 90, 529-539.
93. Lazdunski, C.J., Bouveret, E., Rigal, A., Journet, L., Lloubes, R. and Benedetti, H. (1998) Colicin import into Escherichia coli cells. Journal of Bacteriology 180, 4993-5002.
94. Lewis, K. (2001) Riddle of biofilm resistance. Antimicrobial Agents and Chemotherapy 45, 999-1007.
95. Loeffler, J.M. and Fischetti, V.A. (2003) Synergistic lethal effect of a combination of phage lytic enzymes with different activities on penicillinsensitive and-resistant Streptococcus pneumoniae strains. Antimicrobial Agents and Chemotherapy 47, 375-377.
96. Loeffler, J.M., Nelson, D. and Fischetti, V.A. (2001) Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 294, 2170-2172.
97. Loeffler, J.M., Djurkovic, S. and Fischetti, V.A. (2003) Phage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremia. Infection and Immunity 71, 6199-6204.
98. Loessner, M.J. (2005) Bacteriophage endolysins-current state of research and applications. Current Opinion on Microbiology 8, 480-487.
99. Loessner, M.J., Wendlinger, G. and Scherer, S. (1995) Heterogeneous endolysins in Listeria monocytogenes bacteriophages: a new class of enzymes and evidence for conserved holin genes within the siphoviral lysis cassettes. Molecular Microbiology 16, 1231-1241.
100. Loessner, M.J., Gaeng, S., Wendlinger, G., Maier, S.K. and Scherer, S. (1998) The two-component lysis system of Staphylococcus aureus bacteriophage Twort: a large TTG-start holin and an associated amidase endolysin. FEMS Microbiology Letters 162, 265-274.
101. Lopez, R., Garcia, E., Garcia, P. and Garcia, J.L. (1997) The pneumococcal cell wall degrading enzymes: a modular design to create new lysins? Microbial Drug Resistance 3, 199-211.
102. Low, L.Y., Yang, C., Perego, M., Osterman, A. and Liddington, R.C. (2005) Structure and lytic activity of a Bacillus anthracis prophage endolysin. Journal of Biological Chemistry 280, 35433-35439.
103. Masschalck, B. and Michiels, C.W. (2003) Antimicrobial properties of lysozyme in relation to foodborne vegetative bacteria. Critical Reviews of Microbiology 29, 191-214.
104. McCullers, J.A., Karlstrom, A., Iverson, A.R., Loeffler, J.M. and Fischetti, V.A. (2007) Novel strategy to prevent otitis media caused by colonizing Streptococcus pneumoniae. PLoS Pathogens 3, e28.
105. Mitchell, G.J., Nelson, D.C. and Weitz, J.S. (2010) Quantifying enzymatic lysis: estimating the combined effects of chemistry, physiology and physics. Physical Biology 7, 046002.
106. Mushtaq, N., Redpath, M.B., Luzio, J.P. and Taylor, P.W. (2005) Treatment of experimental Escherichia coli infection with recombinant bacteriophage-derived capsule depolymerase. Journal of Antimicrobial Chemotherapy 56, 160-165.
107. Muyombwe, A., Tanji, Y. and Unno, H. (1999) Cloning and expression of a gene encoding the lytic functions of Bacillus amyloliquefaciens phage: evidence of an auxiliary lysis system. Journal of Bioscience and Engineering 88, 221-225.
108. Nakayama, K., Takashima, K., Ishihara, H., Shinomiya, T., Kageyama, M., Kanaya, S., Ohnishi, M., Murata, T., Mori, H. and Hayashi, T. (2000) The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Molecular Microbiology 38, 213-231.
109. Navarre, W.W., Ton-That, H., Faull, K.F. and Schneewind, O. (1999) Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity. Journal of Biological Chemistry 274, 15847-15856.
110. Nelson, D., Loomis, L. and Fischetti, V.A. (2001) Prevention and elimination of upper respiratory colonization of mice by group A streptococci using a bacteriophage lytic enzyme. Proceedings of the National Academy of Science USA 98, 4107-4112.
111. Nelson, D., Schuch, R., Zhu, S., Tscherne, D.M. and Fischetti, V.A. (2003) The genomic sequence of C1: the first streptococcal phage. Journal of Bacteriology 185, 3325-3332.
112. Nelson, D., Schuch, R., Chahales, P., Zhu, S. and Fischetti, V.A. (2006) PlyC: a multimeric bacteriophage lysin. Proceedings of the National Academy of Science USA 103, 10765-10770.
113. Nelson, D.C., Rodriguez, L., Schmelcher, M., Klumpp, J. and Donovan, D.M. (2012) Endolysins as antimicrobials. Advances in Virus Research.
114. O'Flaherty, S., Coffey, A., Edwards, R., Meancy, W., Fitzgerald, G.F. and Ross, R.P. (2004) Genome of staphylococcal phage K: a new lineage of Myoviridae infecting Gram-positive bacteria with a low G+C content. Journal of Bacteriology 186, 2862-2871.
115. O'Flaherty, S., Coffey, A., Meaney, W., Fitzgerald, G.F. and Ross, R.P. (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. Journal of Bacteriology 187, 7161-7164.
116. Okamoto, K., Mudd, J.A., Mangan, J., Huang, W.M., Subbaiah, T.V. and Marmur, J. (1968) Properties of the defective phage of Bacillus subtilis. Journal of Molecular Biology 34, 413-428.
117. Orito, Y., Morita, M., Hori, K., Unno, H. and Tanji, Y. (2004) Bacillus amyloliquefaciens phage endolysin can enhance permeability of Pseudomonas aeruginosa outer membrane and induce cell lysis. Applied Microbiology and Biotechnology 65, 105-109.
118. Paradis-Bleau, C., Cloutier, I., Lemieux, L., Sanschagrin, F., Laroche, J., Auger, M., Garnier, A. and Levesque, R.C. (2007) Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage φKZ gp144 lytic transglycosylase. FEMS Microbiology Letters 266, 201-209.
119. Pastagia, M., Euler, C., Chahales, P., Fuentes-Duculan, J., Krueger, J.G. and Fischetti, V.A. (2011) A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and-sensitive Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 55, 738-744.
120. Patron, R.L., Climo, M.W., Goldstein, B.P. and Archer, G.L. (1999) Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrobial Agents and Chemotherapy 43, 1754-1755.
121. Porter, C.J., Schuch, R., Pelzek, A.J., Buckle, A.M., McGowan, S., Wilce, M.C., Rossjohn, J., Russell, R., Nelson, D., Fischetti, V.A. and Whisstock, J.C. (2007) The 1.6 Å crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis. Journal of Molecular Biology 366, 540-550.
122. Pritchard, D.G., Dong, S., Baker, J.R. and Engler, J.A. (2004) The bifunctional peptidoglycan lysin of Streptococcus agalactiae bacteriophage B30. Microbiology 150, 2079-2087.
123. Pritchard, D.G., Dong, S., Kirk, M.C., Cartee, R.T. and Baker, J.R. (2007) LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiae. Applied and Environmental Microbiology 73, 7150-7154.
124. Pugsley, A.P. and Schwartz, M. (1983a) Expression of a gene in a 400-base-pair fragment of colicin plasmid ColE2-P9 is sufficient to cause host cell lysis. Journal of Bacteriology 156, 109-114.
125. Pugsley, A.P. and Schwartz, M. (1983b) A genetic approach to the study of mitomycin-induced lysis of Escherichia coli K-12 strains which produce colicin E2. Molecular and General Genetics 190, 366-372.
126. Rakieten, M.L. (1933) The effect of staphylococcus bacteriophage lysin on resistant strains of staphylococci. Journal of Immunology 25, 127-137.
127. Rashel, M., Uchiyama, J., Ujihara, T., Uehara, Y., Kuramoto, S., Sugihara, S., Yagyu, K., Muraoka, A., Sugai, M., Hiramatsu, K., Honke, K. and Matsuzaki, S. (2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage phi MR11. Journal of Infectious Diseases 196, 1237-1247.
128. Rea, M.C., Ross, R.P., Cotter, P.D. and Hill, C. (2011) Classification of bacteriocins from Grampositive bacteria. In: Drider, D. and Rebuffat, S. (eds) Prokaryotic Antimicrobial Peptides: From Genes to Applications. Springer, New York, NY, pp. 29-53.
129. Reanney, D.C. and Ackermann, H.W. (1982) Comparative biology and evolution of bacteriophages. Advances in Virus Research 27, 205-280.
130. Reynals, F.D. (1926) Bacteriophage et microbes tues. Comptes Rendus de la Société de Biologie 94, 242-243.
131. Rigden, D.J., Jedrzejas, M.J. and Galperin, M.Y. (2003) Amidase domains from bacterial and phage autolysins define a family of γ-D, Lglutamate-specific amidohydrolases. Trends in Biochemical Sciences 28, 230-234.
132. Rodriguez, L., Martinez, B., Zhou, Y., Rodriguez, A., Donovan, D.M. and Garcia, P. (2011) Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiology 11, 138.
133. Rodriguez-Cerrato, V., Garcia, P., Huelves, L., Garcia, E., Del Prado, G., Gracia, M., Ponte, C., Lopez, R. and Soriano, F. (2007) Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly β-lactam-resistant Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 51, 3371-3373.
134. Sass, P. and Bierbaum, G. (2007) Lytic activity of recombinant bacteriophage φ11 and φ12 endolysins on whole cells and biofilms of Staphylococcus aureus. Applied and Environmental Microbiology 73, 347-352.
135. Schindler, C.A. and Schuhardt, V.T. (1964) Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proceedings of the National Academy of Science USA 51, 414-421.
136. Schmelcher, M., Tchang, V.S. and Loessner, M.J. (2011) Domain shuffling and module engineering of Listeria phage endolysins for enhanced lytic activity and binding affinity. Microbial Biotechnology 5, 651-662.
137. Schuch, R., Nelson, D. and Fischetti, V.A. (2002) A bacteriolytic agent that detects and kills Bacillus anthracis. Nature 418, 884-889.
138. Silva-Martin, N., Molina, R., Angulo, I., Mancheno, J.M., Garcia, P. and Hermoso, J.A. (2010) Crystallization and preliminary crystallographic analysis of the catalytic module of endolysin from Cp-7, a phage infecting Streptococcus pneumoniae. Acta Crystallographica F Structural Biology and Crystallization Communications 66, 670-673.
139. Smarda, J. and Smajs, D. (1998) Colicins-exocellular lethal proteins of Escherichia coli. Folia Microbiologica 43, 563-582.
140. Stewart, P.S. and Franklin, M.J. (2008) Physiological heterogeneity in biofilms. Nature Reviews Microbiology 6, 199-210.
141. Stoodley, P., Sauer, K., Davies, D.G. and Costerton, J.W. (2002) Biofilms as complex differentiated communities. Annual Review of Microbiology 56, 187-209.
142. Strauch, E., Kaspar, H., Schaudinn, C., Dersch, P., Madela, K., Gewinner, C., Hertwig, S., Wecke, J. and Appel, B. (2001) Characterization of enterocoliticin, a phage tail-like bacteriocin and its effect on pathogenic Yersinia enterocolitica strains. Applied and Environmental Microbiology 67, 5634-5642.
143. Strauch, E., Kaspar, H., Schaudinn, C., Damasko, C., Konietzny, A., Dersch, P., Skurnik, M. and Appel, B. (2003) Analysis of enterocoliticin, a phage tail-like bacteriocin. Advances in Experimental Medicine and Biology 529, 249-251.
144. Sutherland, I.W., Hughes, K.A., Skillman, L.C. and Tait, K. (2004) The interaction of phage and biofilms. FEMS Microbiology Letters 232, 1-6.
145. Takac, M. and Blasi, U. (2005) Phage P68 virionassociated protein 17 displays activity against clinical isolates of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 49, 2934-2940.
146. Taylor, A. and Gorazdowska, M. (1974) Conversion of murein to non-reducing fragments by enzymes from phage lambda and Vi II lysates. Biochimica et Biophysica Acta 342, 133-136.
147. Thumm, G. and Gotz, F. (1997) Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Molecular Microbiology 23, 1251-1265.
148. Thurow, H., Niemann, H., Rudolph, C. and Stirm, S. (1974) Host capsule depolymerase activity of bacteriophage particles active on Klebsiella K20 and K24 strains. Virology 58, 306-309.
149. Thurow, H., Niemann, H. and Stirm, S. (1975) Bacteriophage-borne enzymes in carbohydrate chemistr. Part I. On the glycanase activity associated with particles of Klebsiella bacteriophage No. 11. Carbohydrate Research 41, 257-271.
150. Twort, F.W. (1915) An investigation on the nature of ultra-microscopic viruses. Lancet 186, 1241-1246.
151. Twort, F.W. (1925) The transmissible bacterial lysin and its action on dead bacteria. Lancet 206, 642-644.
152. Vaara, M. (1992) Agents that increase the permeability of the outer membrane. Microbiological Reviews 56, 395-411.
153. Vandenbergh, P.A., Wright, A.M. and Vidaver, A.K. (1985) Partial purification and characterization of a polysaccharide depolymerase associated with phage-infected Erwinia amylovora. Applied and Environmental Microbiology 49, 994-996.
154. Veiga-Crespo, P. and Villa, T.G. (2010) Advantages and disadvantages in the use of antibiotics or phages as therapeutic agents. In: Veiga-Crespo, P. and Villa, T.G. (eds) Enzybiotics. John Wiley & Sons, Hoboken, NJ, pp. 27-58.
155. Veiga-Crespo, P., Ageitos, J.M., Poza, M. and Villa, T.G. (2007) Enzybiotics: a look to the future, recalling the past. Journal of Pharmaceutical Sciences 96, 1917-1924.
156. Wang, I.-N., Smith, D.L. and Young, R. (2000) Holins: the protein clocks of bacteriophage infections. Annual Review of Microbiology 54, 799-825.
157. Waseh, S., Hanifi-Moghaddam, P., Coleman, R., Masotti, M., Ryan, S., Foss, M., MacKenzie, R., Henry, M., Szymanski, C.M. and Tanha, J. (2010) Orally administered P22 phage tailspike protein reduces Salmonella colonization in chickens: prospects of a novel therapy against bacterial infections. PLoS One 5, e13904.
158. Whatmore, A.M. and Reed, R.H. (1990) Determination of turgor pressure in Bacillus subtilis: a possible role for K+ in turgor regulation. Journal of General Microbiology 136, 2521-2526.
159. Witzenrath, M., Schmeck, B., Doehn, J.M., Tschernig, T., Zahlten, J., Loeffler, J.M., Zemlin, M., Muller, H., Gutbier, B., Schütte, H., Hippenstiel, S., Fischetti, V.A., Suttorp, N. and Rosseau, S. (2009) Systemic use of the endolysin Cpl-1 rescues mice with fatal pneumococcal pneumonia. Critical Care Medicine 37, 642-649.
160. Yoong, P., Schuch, R., Nelson, D. and Fischetti, V.A. (2006) PlyPH, a bacteriolytic enzyme with a broad pH range of activity and lytic action against Bacillus anthracis. Journal of Bacteriology 188, 2711-2714.
161. Young, R. (1992) Bacteriophage lysis: mechanism and regulation. Microbiological Reviews 56, 430-481.
162. Yurewicz, E.C., Ghalambor, M.A., Duckworth, D.H. and Heath, E.C. (1971) Catalytic and molecular properties of a phage-induced capsular polysaccharide depolymerase. Journal of Biological Chemistry 246, 5607-5616.